High Serum Transforming Growth Factor- 1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated With Sorafenib
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-1954
Full Text
Open PDFAbstract
Available in full text
Date
May 14, 2015
Authors
Publisher
American Association for Cancer Research (AACR)